Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Bindu George

FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma

Clinical Cancer Research

Cancer Research

English

Management of Cervical Cystic Hygroma With Recurrent Pneumonia

Journal of Evolution of Medical and Dental Sciences

English

Related publications

Preliminary Results of Earlier Steroid Use With Axicabtagene Ciloleucel (Axi-Cel) in Patients With Relapsed/Refractory Large B Cell Lymphoma

Hematological Oncology

Cancer Research

English

Safety and Efficacy of Axicabtagene Ciloleucel in Refractory Large B-Cell Lymphomas

Therapeutic Advances in Hematology

English

Emerging Therapies for the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma

Current Oncology

English

FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia With an Isocitrate Dehydrogenase-1 Mutation

Clinical Cancer Research

Cancer Research

English

Axicabtagene Ciloleucel for CD19+ Plasmablastic Lymphoma

American Journal of Hematology

English

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Annals of Hematology

English

Phase 2 Study of Parsaclisib (Incb050465) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (Dlbcl) (Citadel-202)

Hematological Oncology

Cancer Research

English

Bone Marrow Molecular Markers Associated With Relapsed/Refractory Activated B-Cell-Like Diffuse Large B-Cell Lymphoma

BioMed Research International

Molecular Biology

English

Outcomes of Patients ≥ 65 Years of Age in Zuma-1, a Pivotal Phase 1/2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Refractory Large B Cell Lymphoma

Hematological Oncology

Cancer Research

English